BioLife Solutions, Inc. Line of Credit, Current
BioLife Solutions, Inc. (BLFS) had Line of Credit, Current of $2.16 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2021-11-15
- 2021-09-30: Line of Credit, Current $2.16M.
- 2021-06-30: Line of Credit, Current $3.37M.
- 2020-12-31: Line of Credit, Current $0.00.
| Period end | Line of Credit, Current |
|---|---|
| 2021-09-30 | $2.16M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.37M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |